Aurora Cannabis Inc.

ACB

CA05156X8504

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
6.32 ^CAD	-2.77%		-10.10%	-2.77%

06-20	Aurora Cannabis Down 7.2% as it Trims Its Fiscal Q4 Loss	MT
06-20	Toronto Stocks Advance, Empire Shares Up on Adjusted Profit, Revenue Beats	DJ

Aurora Cannabis Inc. cancelled the transaction announced on June 3, 2016

January 12, 2018

On January 13, 2018, Aurora Cannabis Inc. (TSX:ACB) cancelled the transaction.

Latest news about Aurora Cannabis Inc.

Aurora Cannabis Down 7.2% as it Trims Its Fiscal Q4 Loss	06-20	MT
Toronto Stocks Advance, Empire Shares Up on Adjusted Profit, Revenue Beats	06-20	DJ
Transcript : Aurora Cannabis Inc., 2024 Earnings Call, Jun 20, 2024	06-20
Aurora Cannabis Trims Q4 Net Loss	06-20	MT
Aurora Cannabis Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	06-20	CI
Aurora Cannabis Brief: Re-Affirming Target of Reaching Positive Free Cash Flow by December 31, 2024	06-20	MT
Aurora Cannabis Brief: Says Q4 Represents Sixth Consecutive Quarter of Positive Adjusted EBITDA; Adds Ended Fiscal Year with a Cash Position of Near $180 Million with Cannabis Business Debt-Free	06-20	MT
Aurora Cannabis Brief: Q4 Revenues $67.4 million Vs Forecast As Per Capital IQ of $69.54 Million and Last Year $64.03 Million	06-20	MT
Aurora Cannabis Inc. Provides Consolidated Earnings Guidance for the First Quarter Ending June 30, 2024	06-20	CI
Aurora Cannabis Introduces Resin Cartridges in Australia	06-05	MT
Aurora Cannabis Brief: Unveiling Premium Resin Cartridges in Australia	06-05	MT
US Government Reclassifies Marijuana to Less-Restrictive Category	05-16	MT
Justice Department Set to Post Cannabis Reclassification Plans	05-16	MT
Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors	05-15	CI
Aurora Cannabis Inc. Marks First Shipment of Medical Cannabis to the New Zealand Market	05-14	CI
Aurora Cannabis Brief: Up 0.3% In US Premarket As Marks First Shipment of Medical Cannabis to the New Zealand Market	05-08	MT
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	04-30	DJ
TSX Down More Than 1% Today and More Than 2% For April, Having Hit Record Highs Earlier In the Month; But Cannabis Stocks Hit a High	04-30	MT
Sector Update: Consumer Stocks Slipping in Late Afternoon Trading	04-30	MT
Cannabis Stocks Jump on Report DEA to Reclassify Marijuana as Less Dangerous Drug	04-30	MT
Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug	04-30	MT
DEA to Move to Reclassify Marijuana, Associated Press Reports	04-30	MT
Aurora Cannabis Up 0.15% In US Premarket As Expands Offerings in Australia with New Range of Premium Dried Flower Products	04-30	MT
Aurora Cannabis Brief: Expanding Offerings in Australia with New Range of Premium Dried Flower Products	04-30	MT
Aurora Cannabis Inc. in Conjunction with MedReleaf Australia, Announce Expansion of its Portfolio with Introduction of New Range of Premium Dried Cannabis Flower Products	04-30	CI

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Companyâs segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Aurora Cannabis Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

6.32 CAD

Average target price

8.431 CAD

Spread / Average Target

+33.41%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
AURORA CANNABIS INC.	-2.77%	252M
DONG-E-E-JIAO CO.,LTD.	+26.93%	5.55B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-33.55%	3.52B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-3.74%	3.03B
TASLY PHARMACEUTICAL GROUP CO., LTD	-26.09%	2.59B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-10.93%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.88B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+41.84%	1.46B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-12.94%	1.43B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+47.62%	1.42B

Alternative Medicine